FDA — authorised 29 September 2023
- Application: NDA215842
- Marketing authorisation holder: NOVO
- Local brand name: RIVFLOZA
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 Rivfloza in United States
FDA authorised Rivfloza on 29 September 2023
Marketing authorisations
FDA
- Marketing authorisation holder: NOVO
- Status: approved
Rivfloza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Rivfloza approved in United States?
Yes. FDA authorised it on 29 September 2023; FDA has authorised it.
Who is the marketing authorisation holder for Rivfloza in United States?
NOVO holds the US marketing authorisation.